COST-EFFECTIVENESS OF THE CELL-BASED QUADRIVALENT VERSUS THE STANDARD EGG-BASED QUADRIVALENT INFLUENZA VACCINE IN GERMANY.

被引：0
|
作者：
Cai, R. [1 ]
Eichner, M. [2 ]
Schwehm, M. [3 ]
Rajaram, S. [4 ]
Joaquin, F. M. Q. [5 ]
Lamotte, M. [6 ]
机构：
[1] IQVIA, Amsterdam, Netherlands
[2] Univ Tubingen, Tubingen, Germany
[3] ExploSYS GmbH, Leinfelden Echterdingen, Germany
[4] Seqirus, Maidenhead, Berks, England
[5] Seqirus, Summit, NJ USA
[6] IQVIA, Zaventem, Belgium
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN32
引用
收藏
页码：S548 / S548
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
    You, Joyce H. S.
    Ming, Wai-kit
    Chan, Paul K. S.
    BMC INFECTIOUS DISEASES, 2014, 14
  • [22] Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
    Joyce HS You
    Wai-kit Ming
    Paul KS Chan
    BMC Infectious Diseases, 14
  • [23] COST-EFFECTIVENESS OF SEASONAL VACCINATION WITH QUADRIVALENT INFLUENZA VACCINE IN PORTUGAL
    Almeida, J.
    Ferreira, C.
    Monteiro, S.
    VALUE IN HEALTH, 2019, 22 : S651 - S651
  • [24] The cost-effectiveness of an adjuvanted quadrivalent influenza vaccine in the United Kingdom
    Kohli, Michele A.
    Maschio, Michael
    Mould-Quevedo, Joaquin F.
    Drummond, Michael
    Weinstein, Milton C.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (11) : 4603 - 4610
  • [25] Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax® Tetra/Flucelvax Quadrivalent®): A Review in the Prevention of Influenza
    Yvette N. Lamb
    Drugs, 2019, 79 : 1337 - 1348
  • [26] Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax® Tetra/Flucelvax Quadrivalent®): A Review in the Prevention of Influenza
    Lamb, Yvette N.
    DRUGS, 2019, 79 (12) : 1337 - 1348
  • [27] COST-EFFECTIVENESS OF QUADRIVALENT VERSUS TRIVALENT INFLUENZA VACCINES FOR CHILDREN
    Yang, M. C.
    Tan, C. H.
    VALUE IN HEALTH, 2014, 17 (03) : A161 - A161
  • [28] A randomized controlled trial of antibody response to 2018-19 cell-based vs. egg-based quadrivalent inactivated influenza vaccine in children
    Moehling, Krissy K.
    Zimmerman, Richard K.
    Nowalk, Mary Patricia
    Lin, Chyongchiou Jeng
    Martin, Judith M.
    Alcorn, John F.
    Susick, Michael
    Burroughs, Ashley
    Holiday, Crystal
    Flannery, Brendan
    Levine, Min Z.
    VACCINE, 2020, 38 (33) : 5171 - 5177
  • [29] Safety and Immunogenicity of Cell-Based Quadrivalent Influenza Vaccine: A Randomized Trial
    Essink, Brandon J.
    Heeringa, Marten
    Jeanfreau, Robert J.
    Finn, Daniel
    Matassa, Vince
    Edelman, Jonathan
    Hohenboken, Matthew
    Molrine, Deborah
    PEDIATRICS, 2022, 150 (05)
  • [30] Correction to: Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax® Tetra/Flucelvax Quadrivalent®): A Review in the Prevention of Influenza
    Yvette N. Lamb
    Drugs, 2019, 79 : 2009 - 2009
12345